Heterologous desensitization of opioid-stimulated Ca2+ increase by bradykinin or ATP in NG108-15 cells

J Biol Chem. 1995 Jul 14;270(28):16630-7. doi: 10.1074/jbc.270.28.16630.

Abstract

Leucine-enkephalin (Leu-EK) dose-dependently elicited an increase in cytosolic Ca2+ concentration ([Ca2+]i) with an EC50 of 1.2 microM via the phosphoinositide cascade in NG108-15 cells. Chronic treatment of cells with [D-Ala2,D-Leu5]enkephalin caused time-dependent homologous desensitization. In the presence of extracellular Ca2+, ATP as well as bradykinin stimulated significantly higher increases in inositol 1,4,5-trisphosphate (IP3) generation than did Leu-EK; however, the magnitude of intracellular Ca2+ pools increased after ATP stimulation, whereas bradykinin depleted intracellular pools. Hence, cells lost their [Ca2+]i response to Leu-EK if bradykinin was first added to induce a [Ca2+]i increase, whereas the response was unchanged if Leu-EK was added after addition of ATP. When Leu-EK was added simultaneously with bradykinin or ATP, an additive response was observed in IP3 generation; however, the rise in [Ca2+]i reached the same level as that induced by bradykinin or ATP alone. In the absence of extracellular Ca2+ in which the replenishment of intracellular pools was not possible, ATP displayed an inhibitory effect similar to that of bradykinin on the Leu-EK-induced [Ca2+]i increase. Prior treatment of cells with Leu-EK slightly heterologously desensitized the action of bradykinin, but had no effect on the ATP response. Our results suggest that a shared intracellular Ca2+ pool is sensitive to the opioid, bradykinin and P2-purinoceptor agonists; however, a defined pool of phosphatidylinositol 4,5-bisphosphate or a specific phospholipase C is responsible for each receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Bradykinin / pharmacology*
  • Calcium / metabolism*
  • Cyclic AMP / biosynthesis
  • Enkephalin, Leucine / pharmacology*
  • Enkephalin, Leucine-2-Alanine / pharmacology
  • Glioma / metabolism
  • Glioma / pathology
  • Inositol 1,4,5-Trisphosphate / biosynthesis
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology
  • Receptors, Opioid, delta / drug effects
  • Tumor Cells, Cultured

Substances

  • Receptors, Opioid, delta
  • Enkephalin, Leucine
  • Enkephalin, Leucine-2-Alanine
  • Inositol 1,4,5-Trisphosphate
  • Adenosine Triphosphate
  • Cyclic AMP
  • Bradykinin
  • Calcium